Артериальная гипертония и бронхиальная астма: ключевые факторы риска

Современная медицина сталкивается с увеличением числа пациентов, страдающих одновременно несколькими хроническими заболеваниями. Наличие двух или более заболеваний увеличивает сложность диагностики, подбора адекватной терапии и ухода за пациентом. Люди с сочетанием нескольких хронических неинфекционных заболеваний чаще сталкиваются с инвалидизацией, ограничениями в повседневной активности и снижением качества жизни. Распространенность сердечно-сосудистых заболеваний и болезней бронхолегочной системы остается по-прежнему высокой. Кроме того, зачастую они имеют общие факторы риска и патогенетические взаимодействия. В данной статье рассматривается проблема сочетания бронхиальной астмы и артериальной гипертензии с позиций общих факторов риска и патофизиологических взаимосвязей.

1. Bush A. Pathophysiological Mechanisms of Asthma // Front. Pediatr. 2019. Vol. 7. P. 68. https://doi.org/10.3389/fped.2019.00068.

2. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 // Lancet. 2020. Vol. 396, № 10258. P. 1204–22. https://doi.org/10.1002/dmrr.3572/v2/review1.

3. Chuchalin A. G., Khaltaev N., Antonov N. S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation // Int. J. Chron. Obstruct. Pulmon. Dis. 2014. Vol. 9, № 1. P. 963–974. https://doi.org/10.2147/COPD.S67283.

4. Rogliani P., Sforza M., Calzetta L. The impact of comorbidities on severe asthma // Curr. Opin. Pulm. Med. 2020. Vol. 26. P. 47–55. https://doi.org/10.1097/MCP.0000000000000640.

5. Tay T. R., Hew M. Comorbid “treatable traits” in difficult asthma: Current evidence and clinical evaluation // Allergy. 2017. Vol. 73. P. 1369–1382. https://doi.org/10.1111/all.13370.

6. Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension // European heart journal. 2018. Vol. 33, № 39. P. 3021–3104. https://doi.org/10.1097/hjh.0000000000002017.

7. Yaacoub S., Boudaka A., AlKhatib A. et al. The pharmaco-epigenetics of hypertension: a focus on microRNA. Mol Cell Biochem. 2024. Vol. 479, № 12. P. 3255–3271. https://doi.org/10.1007/s11010-024-04947-9.

8. Cazzola M., Calzetta L., Bettoncelli G. et al. Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study // Respir Med. 2012. Vol. 106. P. 249–56. https://doi.org/10.1016/j.rmed.2011.07.021.

9. Zhao R., Xu R., Yuan J. et al. Asthma risk: the inseparable synergy of obesity and metabolism // BMC Pulm Med. 2025. Vol. 25. Art. 409. https://doi.org/10.1186/s12890-025-03878-5.

10. Chen Y., Dales R., Krewski D., Breithaupt K. Increased effects of smoking and obesity on asthma among female Canadians: the National Population Health Survey, 1994-1995 // Am J Epidemiol. 1999. Vol. 150, № 3. P. 255–62. https://doi.org/10.1093/oxfordjournals.aje.a009996.

11. Çolak Y., Afzal S., Nordestgaard B. G., Lange P. Characteristics and prognosis of never-smokers and smokers with asthma in the Copenhagen General Population Study. A prospective cohort study // Am J Respir Crit Care Med. 2015. Vol. 192. P. 172–81. https://doi.org/10.1164/rccm.201502-0302oc.

12. Braido F., Brusselle G., Guastalla D. et al. Determinants and impact of suboptimal asthma control in Europe: the International Cross-sectional and Longitudinal Assessment on Asthma Control (LIAISON) study // Respir Res. 2016. Vol. 17. P. 51. https://doi.org/10.1186/s12931-016-0374-z.

13. James A. L., Palmer L. J., Kicic E. et al. Decline in lung function in the Busselton health study: the effects of asthma and cigarette smoking // Am J Respir Crit Care Med. 2005. Vol. 171. P. 109–114. https://doi.org/10.1164/rccm.200402-230oc.

14. Takahashi K., Pavlidis S., Ng Kee Kwong F. et al. Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis // Eur Respir J. 2018. Vol. 51. P. 1702173. https://doi.org/10.1183/13993003.02173-2017.

15. Strzelak A., Ratajczak A., Adamiec A., Feleszko W. Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review // Int J Environ Res Public Health. 2018. Vol. 15. P. 1033. https://doi.org/10.3390/ijerph15051033.

16. Klein D. K., Silberbrandt A., Frøssing L. et al. Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma // Eur Respir J. 2022. Vol. 60. P. 2102446. https://doi.org/10.1183/13993003.02446-2021.

17. Wu D., Lai T., Yuan Y. et al. Elevated expression of placental growth factor is associated with airway-wall vascular remodelling and thickening in smokers with asthma // Sci Rep. 2017. Vol. 7. P. 43017. https://doi.org/10.1038/srep43017.

18. Boulet L.-P., Lemiere C., Archambault F. et al. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation // Chest. 2006. Vol. 129. P. 661–8. https://doi.org/10.1016/s8756-3452(08)70298-6.

19. Stanescu D., Sanna A., Veriter C. et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils // Thorax. 1996. Vol. 51. P. 267–271. https://doi.org/10.1136/thx.51.3.267.

20. Madani A., Alack K., Richter M. J., Krüger K. Immune-regulating effects of exercise on cigarette smoke-induced inflammation // J Inflamm Res. 2018. Vol. 11. P. 155–167. https://doi.org/10.2147/jir.s141149.

21. Middlekauff H. R., Park J., Agrawal H., Gornbein J. A. Abnormal sympathetic nerve activity in women exposed to cigarette smoke: a potential mechanism to explain increased cardiac risk // Am J Physiol Heart Circ Physiol. 2013. Vol. 305. P. H1560–H1567. https://doi.org/10.1152/ajpheart.00502.2013.

22. Rahman S. M., Ji X., Zimmerman L. J. et al. The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer // JCI Insight. 2016. Vol. 1. P. e88814. https://doi.org/10.1172/jci.insight.88814.

23. Freed J. K., Beyer A. M., LoGiudice J. A. et al. Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation // Circ Res. 2014. Vol. 115. P. 525–532. https://doi.org/10.1161/CIRCRESAHA.115.303881.

24. Dikalova A. E., Itani H. A., Nazarewicz R. R. et al. Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension // Circ Res. 2017. Vol. 121. P. 564–574. https://doi.org/10.1161/CIRCRESAHA.117.310933.

25. Dimitriadis K., Narkiewicz K., Leontsinis I. et al. Acute Effects of Electronic and Tobacco Cigarette Smoking on Sympathetic Nerve Activity and Blood Pressure in Humans // Int J Environ Res Public Health. 2022. Vol. 19, № 6. P. 3237. https://doi.org/10.3390/ijerph19063237.

26. Osei A. D., Mirbolouk M., Orimoloye O. A. et al. The association between e-cigarette use and asthma among never combustible cigarette smokers: Behavioral risk factor surveillance system (BRFSS) 2016 & 2017 // BMC Pulm. Med. 2019. Vol. 19. P. 180. https://doi.org/10.1186/s12890-019-0950-3.

27. Traboulsi H., Cherian M., Abou Rjeili M. et al. Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health // Int. J. Mol. Sci. 2020. Vol. 21. P. 3495. https://doi.org/10.3390/ijms21103495.

28. Hickman E., Jaspers I. Current E-Cigarette Research in the Context of Asthma. Curr. Allergy Asthma Rep. 2020. Vol. 20, № 10. P. 62. https://doi.org/10.1007/s11882-020-00952-2.

29. St Claire S., Gouda H., Schotte K. et al. Lung health, tobacco, and related products: Gaps, challenges, new threats, and suggested research // Am. J. Physiol. Lung Cell Mol. Physiol. 2020. Vol. 318. P. L1004–L1007. https://doi.org/10.1152/ajplung.00101.2020.

30. Casey A. M., Muise E. D., Crotty Alexander L. E. Vaping and e-cigarette use. Mysterious lung manifestations and an epidemic // Curr. Opin. Immunol. 2020. Vol. 66. P. 143–150. https://doi.org/10.1016/j.coi.2020.10.003.

31. Galderisi A., Ferraro V. A., Caserotti M. et al. Protecting youth from the vaping epidemic // Pediatr. Allergy Immunol. 2020. Vol. 31. P. 66–68. https://doi.org/10.1111/pai.13348/v2/response1.

32. Hernandez M. L., Burbank A. J., Alexis N. E. et al. Electronic Cigarettes and Their Impact on Allergic Respiratory Diseases: AWork Group Report of the AAAAI Environmental Exposures and Respiratory Health Committee // J. Allergy Clin. Immunol. Pract. 2021. Vol. 9. P.1142–1151. https://doi.org/10.1016/j.jaip.2020.12.065.

33. Beuther D. A., Sutherland E. R. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies // Am J Respir Crit Care Med. 2007. Vol. 175. P. 661–6. https://doi.org/10.1164/rccm.200611-1717oc.

34. Uysal K. T., Wiesbrock S. M., Marino M. W., Hotamisligil G. S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function // Nature. 1997. Vol. 389. P. 610–614. https://doi.org/10.1038/39335.

35. Ventre J., Doebber T., Wu M. et al. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice // Diabetes. 1997. Vol. 46. P. 1526–1531. https://doi.org/10.2337/diabetes.46.9.1526.

36. Nara N., Nakayama Y., Okamoto S. et al. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance // J. Biol. Chem. 2007. Vol. 282. P. 30794–30803. https://doi.org/10.1074/jbc.M700412200.

37. Huber J., Kiefer F. W., Zeyda M. et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity // J. Clin. Endocrinol. Metab. 2008. Vol. 93. P. 3215–3221. https://doi.org/10.1210/jc.2007-2630.

38. Duffaut C., Zakaroff-Girard A., Bourlier V. et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators // Arterioscler. Thromb. Vasc. Biol. 2009. Vol. 29. P. 1608–1614. https://doi.org/10.1161/ATVBAHA.109.192583.

39. Stefanovic-Racic M., Yang X., Turner M. S. et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver // Diabetes. 2012. Vol. 61. P. 2330–2339. https://doi.org/10.2337/db11-1523.

40. Bertola A., Ciucci T., Rousseau D. et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients // Diabetes. 2012. Vol. 61. P. 2238–2247. https://doi.org/10.2337/db11-1274.

41. Liu J., Divoux A., Sun J. et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice // Nat. Med. 2009. Vol. 15. P. 940–945. https://doi.org/10.1038/nm.1994.

42. Nishimura S., Manabe I., Nagasaki M. et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity // Nat. Med. 2009. Vol. 15. P. 914–920. https://doi.org/10.1038/nm.1964.

43. Sideleva O., Suratt B. T., Black K. E. et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway // Am J Respir Crit Care Med. 2012. Vol. 186, Iss. 7. P. 598–605. https://doi.org/10.1164/rccm.201203-0573oc.

44. Eising J. B., Uiterwaal C. S., Evelein A. M. et al. Relationship between leptin and lung function in young healthy children // Eur Respir J. 2014. Vol. 43. P. 1189–92. https://doi.org/10.1183/09031936.00149613.

45. Kattan M., Kumar R., Bloomberg G. R. et al. Asthma control, adiposity, and adipokines among inner-city adolescents // J Allergy Clin Immunol. 2010. Vol. 125, № 3. P. 584–92. https://doi.org/10.1016/j.jaci.2010.01.053.

46. Sood A., Shore S. A. Adiponectin, Leptin, and Resistin in Asthma: Basic Mechanisms through Population Studies // J Allergy (Cairo). 2013. Vol. 2013. P. 785835. https://doi.org/10.1155/2013/785835.

47. Huang F., Del-Rio-Navarro B. E., Torres-Alcantara S. et al. Adipokines, asymmetrical dimethylarginine, and pulmonary function in adolescents with asthma and obesity // J Asthma. 2017. Vol. 54. P. 153–61. https://doi.org/10.1080/02770903.2016.1200611.

48. Wang Y., Wang Q. J. The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines // Arch Intern Med. 2004. Vol. 164. P. 2126–2134. https://doi.org/10.1001/archinte.164.19.2126.

49. Lohmeier T. E., Iliescu R. The sympathetic nervous system in obesity hypertension // Curr Hypertens Rep. 2013. Vol. 15, № 4. P. 409–16. https://doi.org/10.1007/s11906-013-0356-1.

50. Virdis A. Endothelial dysfunction in obesity: role of inflammation // High Blood Press Cardiovasc Prev. 2016. Vol. 23. P. 83–85. https://doi.org/10.1007/s40292-016-0133-8

51. Peng Y., Croce C. M. The role of MicroRNAs in human cancer // Signal. Transduct. Target. Ther. 2016. Vol. 1. P. 15004. https://doi.org/10.1038/sigtrans.2015.4.

52. Zhang Z., Zhuang L., Lin C.-P. Roles of MicroRNAs in Establishing and Modulating Stem Cell Potential // Int. J. Mol. Sci. 2019. Vol. 20. P. 3643. https://doi.org/10.3390/ijms20153643.

53. Vidigal J. A., Ventura A. The biological functions of miRNAs: Lessons from in vivo studies // Trends Cell Biol. 2015. Vol. 25. P. 137–147. https://doi.org/10.1016/j.tcb.2014.11.004.

54. Vorobeva E. V., Kyyaly M. A., Sones C. L. et al. Circulating microRNAs as Potential Diagnostic Tools for Asthma and for Indicating Severe Asthma Risk // Int. J. Mol. Sci. 2025. Vol. 26. P. 6676. https://doi.org/10.3390/ijms26146676.

55. Zolotareva O., Saik O. V., Königs C. et al. Comorbidity of asthma and hypertension may be mediated by shared genetic dysregulation and drug side effects // Sci Rep. 2019. Vol. 9, № 1. P. 16302. https://doi.org/10.1038/s41598-019-52762-w. PMID: 31705029; PMCID: PMC6841742.

56. Li X., Wei Y., Wang Z. MicroRNA-21 and hypertension // Hypertens Res. 2018. Vol. 41. P. 649–661. https://doi.org/10.1038/s41440-018-0071-z.

57. Ashikha Shirin Usman P. P., Ameya K. P., Sekar D. Revolutionary advances in hypertension detection: Gold nanoparticle-enhanced miRNA-based electrochemical biosensors and emerging nanotechnologies // Human Gene. 2025. Vol. 44. P. 201401. https://doi.org/10.1016/j.humgen.2025.201401.

58. Ozkan G., Ulusoy S., Geyik E., Erdem Y. Down-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertension // J Clin Hypertens (Greenwich). 2019. Vol. 21. P. 1724–1731. https://doi.org/10.1111/jch.13704.

59. Adamcova M., Kawano I., Simko F. The impact of microRNAs in renin-angiotensin-system-induced cardiac remodeling // Int J Mol Sci. 2021. Vol. 22, № 9. P. 4762. https://doi.org/10.3390/ijms22094762.

60. Holtzman J., Lee H. Emerging role of extracellular vesicles in the respiratory system // Exp. Mol. Med. 2020. Vol. 52. P. 887–895. https://doi.org/10.1038/s12276-020-0450-9.

61. Atashbasteh M., Mortaz E., Mahdaviani S. A. et al. Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors // Allergy Asthma Clin. Immunol. 2021. Vol. 17. P. 1–12. https://doi.org/10.1186/s13223-021-00556-z.

62. Ruan J., Yi X. Genomic structural equation modeling elucidates the shared genetic architecture of allergic disorders // J Transl Med. 2025. Vol. 23. P. 445. https://doi.org/10.1186/s12967-025-06465-8.

63. Kyyaly M. A., Vorobeva E. V., Kothalawala D. M. et al. MicroRNAs-a promising tool for asthma diagnosis and severity assessment: A systematic review // J. Pers. Med. 2022. Vol. 12. P. 543. https://doi.org/10.3390/jpm12040543.

64. Zhao M., Juanjuan L., Weijia F. et al. Expression Levels of MicroRNA-125b in Serum Exosomes of Patients with Asthma of Different Severity and its Diagnostic Significance // Curr. Drug Metab. 2019. Vol. 20. P. 781–784. https://doi.org/10.2174/1389200220666191021100001.